Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Syri Limited t/a Thame Laboratories, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK
Dipyridamole 200mg/5ml Oral Suspension.
| Pharmaceutical Form |
|---|
|
Oral Suspension. Yellow coloured suspension with orange flavor. |
Each 5ml of oral suspension contains 200mg dipyridamole.
Excipients with known effect: Each 5ml of oral suspension contains 9mg of methyl parahydroxybenzoate (E218), 0.9mg of propyl parahydroxybenzoate (E216), 2040mg of liquid maltitol (E965) and 545.20mg of propylene glycol (E1520).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dipyridamole |
Dipyridamole is an antithrombotic agent with antiplatelet activity. Dipyridamole has an antithrombotic action based on its ability to modify various aspects of platelet function, such as platelet aggregation, adhesion and survival, which are factors associated with the initiation of thrombus formation. |
| List of Excipients |
|---|
|
Methyl parahydroxybenzoate (E218) |
*ottle: Ph.Eur Type III Amber glass
Closure: Tamper evident, child resistant, plastic (Polypropylene/Polyethylene) cap with an EPE liner.
Dosing Device: Double ended white polypropylene plastic spoon with 2.5ml and 5ml measuring ends.
Pack size: 150ml and 300ml.
Not all pack sizes may be marketed.
Syri Limited t/a Thame Laboratories, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK
PL 39307/0041
06/01/2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
